Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLT ?4.8mm RC, SLActive? 12mm, TiZr, NTP: medical device reports filed with FDA

6,396 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

6,396
device reports naming the brand
0% of all MAUDE reports · about 937 a year
1,030
reports, 12 months to August 2026
1,117 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

6,396 medical device reports received by FDA name the brand "BLT ?4.8mm RC, SLActive? 12mm, TiZr, NTP" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

1,030 reports arrived in the 12 months to August 2026, close to the 1,117 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (65.8%), loss of osseointegration (18.1%) and difficult to insert (2.2%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0127253Sep 2021: 62Oct 2021: 70Nov 2021: 70Dec 2021: 532022Jan 2022: 60Feb 2022: 57Mar 2022: 77Apr 2022: 82May 2022: 81Jun 2022: 75Jul 2022: 62Aug 2022: 84Sep 2022: 66Oct 2022: 84Nov 2022: 114Dec 2022: 722023Jan 2023: 59Feb 2023: 73Mar 2023: 64Apr 2023: 85May 2023: 84Jun 2023: 107Jul 2023: 100Aug 2023: 86Sep 2023: 68Oct 2023: 102Nov 2023: 82Dec 2023: 762024Jan 2024: 79Feb 2024: 93Mar 2024: 73Apr 2024: 102May 2024: 97Jun 2024: 71Jul 2024: 91Aug 2024: 63Sep 2024: 83Oct 2024: 109Nov 2024: 106Dec 2024: 852025Jan 2025: 76Feb 2025: 98Mar 2025: 91Apr 2025: 46May 2025: 0Jun 2025: 253Jul 2025: 81Aug 2025: 89Sep 2025: 97Oct 2025: 104Nov 2025: 76Dec 2025: 1232026Jan 2026: 67Feb 2026: 71Mar 2026: 68Apr 2026: 79May 2026: 87Jun 2026: 80Jul 2026: 84Aug 2026: 94

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

05671,1342019: 44320192020: 53420202021: 70320212022: 91420222023: 98620232024: 1,05220242025: 1,13420252026: 6302026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%6,396
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report73.1%4,677
Voluntary report0%0
User facility report0%0
Distributor report26.9%1,719
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate4,20765.8%62.8%
Loss of osseointegration1,15718.1%22.4%
Difficult to insertthe device was hard to insert1382.2%0.4%
Separation failure190.3%0.1%
Fracturea broken bone70.1%1.6%
Unstable50.1%0%
Defective devicethe device was defective20%0%
Unintended movement20%0%
Mechanics altered10%0%
Positioning problem10%0.1%
Therapeutic or diagnostic output failure10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis1,91930%
Painpain, site not specified1,31320.5%
Tissue damage64210%
Inflammationinflammation5128%
Hemorrhage/blood loss/bleeding3375.3%
Swelling/ edema3064.8%
Abscessa collection of pus2083.3%
Hyperresponsive to stimuli1762.8%
Fistula1472.3%
Hypersensitivity/allergic reaction731.1%
Swellingswelling360.6%
Increased sensitivity260.4%
Failure of implant250.4%
Inadequate osseointegration200.3%
Sinus perforation200.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLT ?4.8mm RC, SLActive? 12mm, TiZr, NTPProduct code DZEAll MAUDE reports
Reports6,3963,924,24126,136,888
Share of that pool—0.2%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer73.1%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLT ?4.8mm RC, SLActive? 12mm, TiZr, NTP reports

How many FDA reports name BLT ?4.8mm RC, SLActive? 12mm, TiZr, NTP?

6,396 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 1,030 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (65.8%), loss of osseointegration (18.1%), difficult to insert (2.2%), separation failure (0.3%) and fracture (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (73.1%) and distributor reports (26.9%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLT ?4.8mm RC, SLActive? 12mm, TiZr, NTP was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.